Let’s start up with the current stock price of AbbVie Inc. (ABBV), which is $106.29 to be very precise. The Stock rose vividly during the last session to $106.75 after opening rate of $104.70 while the lowest price it went was recorded $104.15 before closing at $104.20.
Recently in News on February 12, 2021, AbbVie to Present at the 10th Annual SVB Leerink Global Healthcare Conference. AbbVie (NYSE: ABBV) will participate in the 10th Annual SVB Leerink Global Healthcare Conference on Friday, February 26. Michael Severino, M.D., vice chairman and president, Robert A. Michael, executive vice president and chief financial officer, and Jeffrey R. Stewart, executive vice president, commercial operations, will present virtually at 9:40 a.m. Central time. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
AbbVie Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $113.41 on 01/13/21, with the lowest value was $101.81 for the same time period, recorded on 01/29/21.
AbbVie Inc. (ABBV) full year performance was 13.55%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, AbbVie Inc. shares are logging -6.28% during the 52-week period from high price, and 69.93% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $62.55 and $113.41.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 6929744 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the AbbVie Inc. (ABBV) recorded performance in the market was -0.80%, having the revenues showcasing 7.32% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 186.41B, as it employees total of 47000 workers.
The Analysts eye on AbbVie Inc. (ABBV)
During the last month, 14 analysts gave the AbbVie Inc. a BUY rating, 2 of the polled analysts branded the stock as an OVERWEIGHT, 6 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 99.10, with a change in the price was noted +19.15. In a similar fashion, AbbVie Inc. posted a movement of +21.98% for the period of last 100 days, recording 7,946,344 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ABBV is recording 5.70 at the time of this writing. In addition, long term Debt to Equity ratio is set at 5.39.
Technical rundown of AbbVie Inc. (ABBV)
Raw Stochastic average of AbbVie Inc. in the period of last 50 days is set at 39.98%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 39.67%. In the last 20 days, the company’s Stochastic %K was 28.04% and its Stochastic %D was recorded 23.95%.
Considering, the past performance of AbbVie Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -0.80%. Additionally, trading for the stock in the period of the last six months notably improved by 10.32%, alongside a boost of 13.55% for the period of the last 12 months. The shares increased approximately by 0.84% in the 7-day charts and went up by -3.83% in the period of the last 30 days. Common stock shares were driven by 7.32% during last recorded quarter.